MNKD MannKind Corporation Stock — fundamentals, financials & AI research · AlgoThesis

Stocks›Basic Materials›MNKD

MNKD

Name: AlgoThesis
Author: algothesis

MannKind Corporation

NasdaqResearch view

Basic Materials · Pharmaceutical Preparations · SEC EDGAR FY 2025-12-31

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

Revenue$349.0M

Net Income$5.9M

Gross Profit—

Oper Income$38.8M

EPS (dil)$0.02

Rev/sh$1.13

FCF/sh$0.04

Book/sh$-0.17

Cash/sh$0.24

40+ fundamentals from SEC EDGAR (public domain) — deeper than a typical screener's ratio table.

Revenue & Earnings — fiscal year

$75.4M

2021

$99.8M

2022

$199.0M

2023

$285.5M

2024

$349.0M

2025

Financials — annual

SEC EDGAR · last 5 FY

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$75.4M	$99.8M	$199.0M	$285.5M	$349.0M
Gross Profit	—	—	—	—	—
Operating Income	$-47.0M	$-64.1M	$8.7M	$72.6M	$38.8M
Net Income

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet

COMMUNITY · $MNKD0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Ask AI about MNKD Build basket with MNKD Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.